• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical remission of Merkel cell carcinoma after treatment with imatinib.

作者信息

Loader Dagmara Ewa, Feldmann Robert, Baumgartner Magdalena, Breier Friedrich, Schrama David, Becker Jürgen Christian, Steiner Andreas

机构信息

Department of Dermatology and Venerology, Hietzing Municipal Hospital Vienna, Vienna, Austria.

出版信息

J Am Acad Dermatol. 2013 Oct;69(4):e181-3. doi: 10.1016/j.jaad.2013.03.042.

DOI:10.1016/j.jaad.2013.03.042
PMID:24034390
Abstract
摘要

相似文献

1
Clinical remission of Merkel cell carcinoma after treatment with imatinib.伊马替尼治疗后默克尔细胞癌的临床缓解
J Am Acad Dermatol. 2013 Oct;69(4):e181-3. doi: 10.1016/j.jaad.2013.03.042.
2
KIT mutations in a series of melanomas and their impact on treatment with imatinib.一系列黑色素瘤中的KIT突变及其对伊马替尼治疗的影响。
Actas Dermosifiliogr. 2012 Nov;103(9):838-40. doi: 10.1016/j.ad.2011.10.019. Epub 2012 Jul 15.
3
Treatment of a multicentric Merkel cell carcinoma using imatinib.使用伊马替尼治疗多中心性默克尔细胞癌。
Eur J Dermatol. 2011 Nov-Dec;21(6):1009-10. doi: 10.1684/ejd.2011.1527.
4
[Merkel cell carcinoma: a rare tumor entity in an unusually young patient].
Rofo. 2009 Mar;181(3):270-2. doi: 10.1055/s-0028-1109060. Epub 2009 Feb 19.
5
Overview of Merkel cell carcinoma and recent advances in research.默克尔细胞癌概述及研究新进展
Int J Dermatol. 2003 Sep;42(9):749-51. doi: 10.1046/j.1365-4362.2003.01913.x.
6
Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate.默克尔细胞癌中血小板衍生生长因子受体α的突变状态及免疫组化表达：对甲磺酸伊马替尼治疗的意义
J Cutan Pathol. 2008 Feb;35(2):197-202. doi: 10.1111/j.1600-0560.2007.00793.x.
7
Merkel cell carcinoma: an unusual indication for isolated limb perfusion.默克尔细胞癌：肢体隔离灌注的一种罕见适应证。
Dermatol Online J. 2008 Jul 15;14(7):6.
8
Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.默克尔细胞癌：KIT（CD117）表达评估及未能证实C-KIT原癌基因存在激活突变——对甲磺酸伊马替尼治疗的意义
J Cutan Pathol. 2007 Apr;34(4):324-9. doi: 10.1111/j.1600-0560.2006.00613.x.
9
Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.隆突性皮肤纤维肉瘤：对伊马替尼治疗的部分反应。
Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.
10
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
Dermatol Surg. 2006 Aug;32(8):1097-102. doi: 10.1111/j.1524-4725.2006.32236.x.

引用本文的文献

1
Understanding Merkel Cell Carcinoma: Pathogenic Signaling, Extracellular Matrix Dynamics, and Novel Treatment Approaches.了解默克尔细胞癌：致病信号传导、细胞外基质动态变化及新的治疗方法。
Cancers (Basel). 2025 Apr 2;17(7):1212. doi: 10.3390/cancers17071212.
2
Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma.由病毒癌蛋白驱动的Kit介导的自噬抑制成为默克尔细胞癌的关键生存机制。
Autophagy. 2025 Jul;21(7):1523-1543. doi: 10.1080/15548627.2025.2477385. Epub 2025 Mar 19.
3
Advancing Treatment Options for Merkel Cell Carcinoma: A Review of Tumor-Targeted Therapies.
推进 Merkel 细胞癌的治疗选择：肿瘤靶向治疗的综述。
Int J Mol Sci. 2024 Oct 15;25(20):11055. doi: 10.3390/ijms252011055.
4
Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models.默克尔细胞癌：肿瘤生物学的最新进展、新兴疗法及临床前模型
Front Oncol. 2024 Jul 29;14:1413793. doi: 10.3389/fonc.2024.1413793. eCollection 2024.
5
An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response.分析晚期 Merkel 细胞癌患者中靶向治疗的应用，并评估反应的基因组相关性。
Cancer Med. 2021 Sep;10(17):5889-5896. doi: 10.1002/cam4.4138. Epub 2021 Jul 16.
6
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies.默克尔细胞癌：治疗进展与新兴疗法
Dermatol Ther (Heidelb). 2019 Jun;9(2):209-222. doi: 10.1007/s13555-019-0288-z. Epub 2019 Feb 28.
7
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma.评估强效 BET 降解剂在 Merkel 细胞癌中的治疗潜力。
Neoplasia. 2019 Mar;21(3):322-330. doi: 10.1016/j.neo.2019.01.003. Epub 2019 Feb 21.
8
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities.默克尔细胞癌的生物学和治疗：当前的认识和研究重点。
Nat Rev Clin Oncol. 2018 Dec;15(12):763-776. doi: 10.1038/s41571-018-0103-2.
9
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Merkel 细胞癌的流行病学、生物学和治疗：来自欧盟项目 IMMOMEC 的结论。
Cancer Immunol Immunother. 2018 Mar;67(3):341-351. doi: 10.1007/s00262-017-2099-3. Epub 2017 Nov 30.
10
Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.默克尔细胞癌：流行病学、发病机制、诊断与治疗。
Rev Endocr Metab Disord. 2017 Dec;18(4):517-532. doi: 10.1007/s11154-017-9433-0.